Additionally, a study using a biological nanoparticle delivery method delivered small interfering RNA (siRNA) targeting β-catenin directly into Extracellular vesicles (EVs), resulting in not only reduced growth of HCC cells but also enhanced responsiveness to PD-1 treatment (177). This evidence concerns the gene PDCD1 and hepatocellular carcinoma.